litlas
Log inCreate account

Amy P. Abernethy

Active 2001–2024

128
Papers
27,814
Citations
93
h-index
126
i10-index

Citations

Citations per year for Amy P. Abernethy1996: 1 citations2001: 3 citations2002: 5 citations2003: 19 citations2004: 12 citations2005: 21 citations2006: 19 citations2007: 35 citations2008: 57 citations2009: 41 citations2010: 61 citations2011: 75 citations2012: 132 citations2013: 192 citations2014: 280 citations2015: 330 citations2016: 327 citations2017: 356 citations2018: 289 citations2019: 1,240 citations2020: 1,212 citations2021: 955 citations2022: 706 citations2023: 407 citations2024: 811 citations2025: 314 citations2026: 25 citations1997–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,552 citing papers, 33.4% of this breakdownUnited Kingdom: 949 citing papers, 8.9% of this breakdownAustralia: 611 citing papers, 5.7% of this breakdownCanada: 582 citing papers, 5.5% of this breakdownItaly: 416 citing papers, 3.9% of this breakdownNetherlands: 408 citing papers, 3.8% of this breakdownChina: 400 citing papers, 3.8% of this breakdownGermany: 396 citing papers, 3.7% of this breakdownFrance: 292 citing papers, 2.8% of this breakdownJapan: 221 citing papers, 2.1% of this breakdownSwitzerland: 217 citing papers, 2% of this breakdownSpain: 217 citing papers, 2% of this breakdown
0%33.4%Other 22.4%

Institutions

Fields

  • Medicine68%
  • Health Professions9.9%
  • Economics, Econometrics and Finance7.3%
  • Biochemistry, Genetics and Molecular Biology3.9%
  • Psychology2.9%
  • Social Sciences1.7%
  • Other6.3%

Topics

  • Palliative Care and End-of-Life Issues7.1%
  • Cancer survivorship and care6.5%
  • Economic and Financial Impacts of Cancer3.2%
  • Childhood Cancer Survivors' Quality of Life2.6%
  • Health Systems, Economic Evaluations, Quality of Life2.4%
  • Mobile Health and mHealth Applications2.3%
  • Other75.9%

Coauthors

All papers

Open in search
  1. The Promise of Digital Health: Then, Now, and the Future

    Authors: Verily, Amy P. Abernethy, Laura E. Adams, Meredith Barrett, ResMed, Christine Bechtel, X4 Health, Patricia Brennan, Atul J. Butte, Judith R Faulkner, Epic Systems, Elaine Fontaine, Stephen Friedhoff, John Halamka, Michael D. Howell, Google Health, Kevin Johnson, Peter Long, Blue Shield of California, Deven McGraw, Redonda G. Miller, Peter Lee, Jonathan B. Perlin, The Joint Commission, Donald W. Rucker, 1up Health, Lewis Sandy, UnitedHealth Group, Lucia Savage, Lisa Stump, Paul C. Tang, Eric J. Topol, Reed V. Tuckson, Kristen Valdes, b.well Connected Health - NAM Perspectives 2022 cited by 440

  2. Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    Authors: Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell, Steven B. Clauser, Lori M. Minasian, Amylou C. Dueck, Tito R. Mendoza, Jennifer L. Hay, Thomas M. Atkinson, Amy P. Abernethy, Deborah Watkins Bruner, Charles S. Cleeland, Jeff A Sloan, Ram Chilukuri, Paul Baumgartner, Andrea Denicoff, Diane St Germain, Ann M. O’Mara, Alice Chen, Joseph Kelaghan, Antonia V. Bennett, Laura Sit, Lauren J. Rogak, A. Barz, Diane Β. Paul, Deborah Schrag - JNCI Journal of the National Cancer Institute 2014 cited by 1,127

  3. Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database

    Authors: Gaurav Singal, Peter G. Miller, Vineeta Agarwala, Gerald Li, Gaurav Kaushik, Daniel Backenroth, Anala Gossai, Garrett M. Frampton, Aracelis Z. Torres, Erik Lehnert, David Bourque, Claire O’Connell, Bryan Bowser, Thomas Caron, Ezra Baydur, Kathi Seidl-Rathkopf, Ivan Ivanov, Garrett Alpha-Cobb, Ameet Guria, Jie He, Shannon Frank, Allen C. Nunnally, Mark Bailey, Ann Jaskiw, Dana Feuchtbaum, Nathan C. Nussbaum, Amy P. Abernethy, Vincent A. Miller - JAMA 2019 cited by 565

  4. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

    Authors: Jennifer S. Temel, Amy P. Abernethy, David C. Currow, John Friend, Elizabeth Manning Duus, Ying Yan, Kenneth C.H. Fearon - The Lancet Oncology 2016 cited by 628

  5. The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience

    Authors: S. Yousuf Zafar, Jeffrey Peppercorn, Deborah Schrag, Donald H. Taylor, Amy Goetzinger, Xiaoyin Zhong, Amy P. Abernethy - The Oncologist 2013 cited by 1,102

  6. Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    Authors: Amylou C. Dueck, Tito R. Mendoza, Sandra A. Mitchell, Bryce B. Reeve, Kathleen M. Castro, Lauren J. Rogak, Thomas M. Atkinson, Antonia V. Bennett, Andrea Denicoff, Ann M. O’Mara, Yuelin Li, Steven B. Clauser, Donna Bryant, James D. Bearden, Theresa A. Gillis, Jay K. Harness, Robert D. Siegel, Diane Β. Paul, Charles S. Cleeland, Deborah Schrag, Jeff A. Sloan, Amy P. Abernethy, Deborah Watkins Bruner, Lori M. Minasian, Ethan Basch - JAMA Oncology 2015 cited by 1,015

  7. Generalist plus Specialist Palliative Care — Creating a More Sustainable Model

    Authors: Timothy E. Quill, Amy P. Abernethy - New England Journal of Medicine 2013 cited by 1,445

  8. Financial toxicity, Part I: a new name for a growing problem.

    Authors: S. Yousuf Zafar, Amy P. Abernethy - 2013 cited by 500

  9. Mobile Health Technology Evaluation

    Authors: Santosh Kumar, Wendy Nilsen, Amy P. Abernethy, Audie A. Atienza, Kevin Patrick, Misha Pavel, William T. Riley, Albert O. Shar, Bonnie Spring, Donna Spruijt‐Metz, Donald Hedeker, Vasant Honavar, Richard L. Kravitz, R. Craig Lefebvre, David C. Mohr, Susan A. Murphy, Charlene C. Quinn, Vladimir Shusterman, Dallas Swendeman - American Journal of Preventive Medicine 2013 cited by 943

  10. Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness

    Authors: Jean S. Kutner, Patrick J. Blatchford, Donald H. Taylor, Christine S. Ritchie, Janet Bull, Diane L. Fairclough, Laura C. Hanson, Thomas W. LeBlanc, Greg Samsa, Steven Wolf, Noreen M. Aziz, David C. Currow, Betty Ferrell, Nina D. Wagner‐Johnston, S. Yousuf Zafar, James F. Cleary, Sandesh Dev, Patricia S. Goode, Arif H. Kamal, Cordt T. Kassner, Elizabeth Kvale, Janelle G. McCallum, Adeboye Ogunseitan, Steven Z. Pantilat, Russell K. Portenoy, Maryjo Prince‐Paul, Jeff A. Sloan, Keith M. Swetz, Charles F. von Gunten, Amy P. Abernethy - JAMA Internal Medicine 2015 cited by 496

  11. Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint

    Authors: Melissa D. Curtis, Sandra D. Griffith, Melisa Tucker, Michael D. Taylor, William B. Capra, Gillis Carrigan, Ben Holzman, Aracelis Z. Torres, Paul You, Brandon Arnieri, Amy P. Abernethy - Health Services Research 2018 cited by 221

  12. The Integration of Clinical Trials With the Practice of Medicine

    Authors: Derek C. Angus, Alison J. Huang, Roger Lewis, Amy P. Abernethy, Robert M. Califf, Martin Landray, Nancy Kass, Kirsten Bibbins‐Domingo, Ali Abbasi, Kaleab Z. Abebe, Amy P. Abernethy, Stacey J. Adam, Derek C. Angus, Jamy D. Ard, Michael Berkwits, Rachel Bender Ignacio, Scott Berry, Deepak L. Bhatt, Kirsten Bibbins‐Domingo, Robert O. Bonow, Marc J. M. Bonten, Sharon A. Brangman, John S. Brownstein, Melinda Buntin, Atul J. Butte, Robert M. Califf, Marion Campbell, Anne Rentoumis Cappola, Anne C. Chiang, Deborah Cook, Steven R. Cummings, Gregory Curfman, Laura J. Esserman, Lee A. Fleisher, Joseph B. Franklin, Ralph Gonzalez, Cynthia Grossman, Tufia C. Haddad, Roy S. Herbst, Adrian F. Hernandez, Diane Holder, Leora Horn, Grant D. Huang, Alison J. Huang, Nancy Kass, Rohan Khera, Walter J. Koroshetz, Harlan M. Krumholz, Martin Landray, Roger Lewis, Tracy A. Lieu, Preeti Malani, Christa Lese Martin, Mark McClellan, Mary Mcdermott, Stephanie R. Morain, Susan A. Murphy, Stuart G. Nicholls, Stephen J. Nicholls, Peter J. O’Dwyer, Bhakti K. Patel, Eric C. Peterson, Sheila A. Prindiville, Joseph S. Ross, Kathy Rowan, Gordon D. Rubenfeld, Christopher Seymour, Rod S Taylor, Joanne Waldstreicher, Tracy Y. Wang - JAMA 2024 cited by 70

  13. The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]

    Authors: Amy P. Abernethy, Tania Shelby‐James, Belinda Fazekas, David Woods, David C. Currow - BMC Palliative Care 2005 cited by 529

  14. American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care

    Authors: Thomas J. Smith, Sarah Temin, Erin R. Alesi, Amy P. Abernethy, Tracy A. Balboni, Ethan Basch, Betty Ferrell, M. Loscalzo, Diane E. Meier, Judith A. Paice, Jeffrey Peppercorn, Mark R. Somerfield, Ellen Stovall, Jamie H. Von Roenn - Journal of Clinical Oncology 2012 cited by 1,332

  15. Diversity, Equity, and Inclusion in Clinical Research: A Path Toward Precision Health for Everyone

    Authors: Vindell Washington, Joseph B. Franklin, Erich Huang, Jessica L. Mega, Amy P. Abernethy - Clinical Pharmacology & Therapeutics 2022 cited by 60

  16. Patient-reported outcomes in cancer care — hearing the patient voice at greater volume

    Authors: Thomas W. LeBlanc, Amy P. Abernethy - Nature Reviews Clinical Oncology 2017 cited by 255

  17. Patient-Oncologist Cost Communication, Financial Distress, and Medication Adherence

    Authors: Christine M. Bestvina, Leah L. Zullig, Christel Rushing, Fumiko Chino, Gregory P. Samsa, Ivy Altomare, James A. Tulsky, Peter A. Ubel, Deborah Schrag, Jon Nicolla, Amy P. Abernethy, Jeffrey Peppercorn, S. Yousuf Zafar - Journal of Oncology Practice 2014 cited by 257

  18. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia

    Authors: David C. Currow, Jennifer S. Temel, Amy P. Abernethy, Janusz Milanowski, John Friend, Kenneth C.H. Fearon - Annals of Oncology 2017 cited by 179

  19. Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer

    Authors: Sean Khozin, Rebecca A. Miksad, Johan Adami, Mariel Elena Boyd, Nicholas R Brown, Anala Gossai, Irene Kaganman, Deborah Kuk, Jillian Motyl Rockland, Richard Pazdur, Aracelis Z. Torres, Jizu Zhi, Amy P. Abernethy - Cancer 2019 cited by 138

  20. Review of Electronic Patient-Reported Outcomes Systems Used in Cancer Clinical Care

    Authors: Roxanne E. Jensen, Claire Snyder, Amy P. Abernethy, Ethan Basch, Arnold L. Potosky, Aaron C. Roberts, Deena R. Loeffler, Bryce B. Reeve - Journal of Oncology Practice 2014 cited by 312

  21. The Burden of Polypharmacy in Patients Near the End of Life

    Authors: Michael J. McNeil, Arif H. Kamal, Jean S. Kutner, Christine S. Ritchie, Amy P. Abernethy - Journal of Pain and Symptom Management 2015 cited by 143

  22. Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set

    Authors: Sandra D. Griffith, Rebecca A. Miksad, Geoff Calkins, Paul You, Nicole G. Lipitz, Ariel B. Bourla, Erin Williams, Daniel J. George, Deborah Schrag, Sean Khozin, William B. Capra, Michael D. Taylor, Amy P. Abernethy - JCO Clinical Cancer Informatics 2019 cited by 107

  23. Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non–Small Cell Lung Cancer in the Community Oncology Setting

    Authors: Carolyn J. Presley, Daiwei Tang, Pamela R. Soulos, Anne C. Chiang, Janina A. Longtine, Kerin B. Adelson, Roy S. Herbst, Weiwei Zhu, Nathan C. Nussbaum, Rachael Sorg, Vineeta Agarwala, Amy P. Abernethy, Cary P. Gross - JAMA 2018 cited by 135

  24. An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer

    Authors: Mark Stewart, Andrew D. Norden, Nancy A Dreyer, Henry J. Henk, Amy P. Abernethy, Elizabeth A. Chrischilles, Lawrence H. Kushi, Aaron S. Mansfield, Sean Khozin, Elad Sharon, Srikesh Arunajadai, Ryan M. Carnahan, Jennifer Christian, Rebecca A. Miksad, Lori C. Sakoda, Aracelis Z. Torres, Emily Valice, Jeff Allen - JCO Clinical Cancer Informatics 2019 cited by 134